Drug Points: tachycardia associated with moxifloxacin.
Siepmann
M
M
Institute of Clinical Pharmacology, Medical Faculty, Technical University, 01307 Dresden, Germany.
Kirch
W
W
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy; D024841:Fluoroquinolones / Q000009:adverse effects* / Q000627:therapeutic use; D006261:Headache / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use; D012852:Sinusitis / Q000150:complications / Q000188:drug therapy; D013610:Tachycardia / Q000139:chemically induced*
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D001241:Aspirin; D000077266:Moxifloxacin